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Abstract
Objectives: Cardiovascular risk can be predicted using lipid ratios such as the atherogenic index which is 
defined as the base 10 logarithm of the ratio of plasma triglyceride (TG) to high density lipoprotein 
cholesterol (HDL-C) – it is a useful prognostic parameter for guiding timely interventions and has also 
been employed as a predictor of cardiovascular risk. However, this is rarely used in the clinical practice in 
developing countries including Nigeria.
Methods: This study was a hospital-based cross-sectional study of 382 hypertensive and diabetic patients 
attending outpatient clinics of a tertiary hospital in Nigeria. Atherogenic risk profile, was categorized as 
low risk (<0.1), intermediate risk (0.1–0.24), and high risk (>0.24). Predictors were established using 
regression analysis. Level of significance was set at p-value of <0.05 and 95% confidence interval.
Results: The mean age of participants was 56±12 years, 31.4% of participants had high atherogenic risk. 
This was higher among female patients (60.0%). Participants with high TC, high LDL, uncontrolled blood 
pressure had odds of 1.64, 1.43 and 1.17 times of developing high atherogenic risk respectively. 
Conclusion: A significant proportion of participants in this study population were at risk of developing 
atherosclerosis. Key identified populations at risk of CVD should be considered for routine artherogenic 
assessment.
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Profil de risque athérogénique chez les patients nigérians hypertendus et 
diabétiques subissant une visite de suivi dans un hôpital tertiaire




Objectifs: Le risque cardiovasculaire peut être prédit à l'aide des ratios lipidiques tels que l'indice 
athérogène, défini comme le logarithme en base 10 du ratio des triglycérides plasmatiques (TG) sur le 
cholestérol lié aux lipoprotéines de haute densité (HDL-C) - il s'agit d'un paramètre pronostique utile pour 
guidant des interventions opportunes et a également été utilisé comme facteur prédictif du risque 
cardiovasculaire. Cependant, cela est rarement utilisé dans la pratique clinique dans les pays en 
développement, y compris le Nigéria.
Méthodes: Cette étude était une étude transversale en milieu hospitalier de 382 patients hypertendus et 
diabétiques fréquentant des cliniques de consultation externe d'un hôpital tertiaire au Nigéria. Le profil de 
risque athérogène a été classé dans les catégories suivantes: risque faible (<0,1), risque intermédiaire 
(0,1–0,24) et risque élevé (> 0,24). Les prédicteurs ont été établis par analyse de régression. Le niveau de 
signification a été fixé à une valeur p de <0,05 et un intervalle de confiance à 95%.
Résultats: L'âge moyen des participants était de 56 ± 12 ans, 31,4% des participants avaient un risque 
athérogène élevé. Ce taux était plus élevé chez les patientes (60,0%). Les participants présentant une 
pression artérielle élevée, un cholestérol LDL élevé et une tension artérielle non contrôlée élevée avaient 
respectivement des chances de développer un risque élevé de risque athérogène de 1,64, 1,43 et 1,17.
Conclusion: Une proportion significative des participants de cette population étudiée présentait un risque 
de développer une athérosclérose. Les populations clés identifiées à risque de MCV doivent être 
considérées pour une évaluation athérogénique de routine.
Mots-clés: athérogène, indices, hypertension, diabète
* Auteur de la correspondance
Ahmed A.
E-mail: ahmedabdelus@yahoo.com
1Department of Epidemiology and Community Health, University of Ilorin, Nigeria.
2Department of Community Medicine and Primary Care, Federal Medical Centre, Abeokuta, Nigeria.
3Department of Internal medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
4Department of Family Medicine, General Hospital, Ilorin, Nigeria.
5Department of Community Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
6Department of Chemical Pathology, University of Ilorin, Ilorin, Nigeria 
Received: September 26, 2018  Accepted: November 21, 2018    Published: December 10, 2018
http://orcid.org/0000-0001-6954-7459
Res. J. of Health Sci. Vol 6(4), Oct./Dec., 2018                                                        209
Research Journal of Health Sciences subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of 
Creative Commons Licence (CC BY-NC-ND 4.0). (http://creativecommons.org/licences/by-nc-nd/4.0). 
http://dx.doi.org/10.4314/rejhs.v6i4.7
Atherogenic risk pattern among hypertension and diabetic patients                  Bolarinwa et al.
near normal LDL-C serum levels, there remains 
risk for future cardiovascular events. 
Hypertriglyceridemia has been identified as an 
independent cardiovascular risk factor (16,17). 
Hypertriglyceridemia is a proxy for atherogenic 
dyslipidemia (elevated triglyceride (TG)) and 
low high-density lipoprotein cholesterol) (17, 
18), a component of the metabolic syndrome and 
a known risk factor for CHD. Despite interaction 
with other lipids that might increase atherogenic 
risk and in-subject variation, elevated TG has 
been shown to be a good predictor of CHD in 
consideration of the HDL-C levels (18) and is 
used in clinical practice to predict atherosclerosis 
(18, 19) The lipid ratio log [TG/HDL-C] 
(atherogenic index) provides an alternative 
simple option for risk stratification. The use of 
this ratio is to reflect the balance between risk and 
protective lipoprotein forces (16) as well as 
acting as a correlate with LDL-C particle size 
(20), LDL-phenotype B, and small HDL-C 
particles (4). This ratio has also been evaluated as 
a prognostic tool in predicting CHD (4) and its 
predictive value far outweighs that of absolute 
lipid parameters (21, 22) as well as the TC /HDL 
ratio (22) given its strong correlation with 
lipoprotein particle size.
Nigeria bears a significant burden of 
hypertension and like other SSA countries is not 
adequately equipped with the necessary 
resources, expertise, and technology to manage 
the CVD sequelae. A rural population in Uganda 
reflected the dominant dyslipidemia pattern to be 
that of low serum HDL-C levels and a good 
 proportion with hypertriglyceridemia (23).
W h e r e a s  t h e r e  a r e  w e l l - r e c o g n i z e d  
recommendations on the use of serum LDL-C 
and TC for cardiovascular risk assessment, there 
is limited progress in addressing concerns with 
low serum HDL-C which may lead to 
underestimation of CHD risk (24). Thus, 
assessment of atherogenic index provides a 
simple and reliable method for point of care risk 
assessment that can be done by healthcare 
providers even within hard-to-reach areas. The 
aim of this study was to assess the atherogenic 
risk profile using the atherogenic index among 
Hypertensive and Diabetic Patients in University 
of Ilorin Teaching Hospital.
METHODS
Study design and study setting
This was a hospital-based cross-
sectional study among registered patients with 
hypertension and diabetes attending outpatient 
clinics (General Outpatient Department and the 
INTRODUCTION
The atherogenic index of plasma (AIP), 
is defined as the base 10 logarithm of the ratio of 
plasma triglyceride (TG) to high density 
lipoprotein cholesterol (HDL-C), and has been 
shown to be significant predictors for metabolic 
d i s turbances  inc luding  dys l ip idemia ,  
atherosclerosis, hypertension and cardiovascular 
 
diseases (CVD) (1,2). The term was proposed by 
Dobiasova and Frohlich to indicate that plasma 
atherogenicity was also a significant independent 
predictor of coronary heart disease (CHD) (3, 4). 
It has been established that an AIP value of less 
than 0.11 is associated with low risk of CHD; the 
values between 0.11 to 0.24 and greater than 0.24 
are associated with intermediate and high risks, 
respectively (5, 6). Sensitivity of AIP has also 
been demonstrated in a cohort of patients 
undergoing coronary angiography, where it was 
found to be better than age, body mass index 
(BMI), waist circumference, type 2 diabetes 
mellitus (DM), blood pressure (BP), smoking, 
TG, total cholesterol (TC), low density 
lipoprotein (LDL-C), HDL-C, and TC/HDL-C, 
in predicting the possibility of positive findings 
(6,7).
In Western populations, dyslipidemia 
among patients with hypertension is a common 
finding. The prevalence of dyslipidemia 
coexisting with hypertension has been estimated 
at 15–24% (8,9). Over 40% of all newly 
diagnosed hypertensive patients have at least one 
lipid abnormality (10). There is limited data on 
the burden of dyslipidemia among patients with 
hypertension in sub-Sahara Africa (SSA) 
whereas; hypertension and dyslipidemia are both 
identified as independent modifiable risk factors 
for CVD. Some studies have suggested that 
dyslipidemia may play a role in the development 
of hypertension via endothelial damage (11) and 
the risk for CVD is higher in the presence of both 
hypertension and dyslipidemia than by the 
individual disease entities (12). In high income 
countries, strategies targeting the reduction of 
serum cholesterol levels provide the single most 
important benefit against CVD resulting from 
coronary heart disease (CHD) (13).
Presently, medical practice encourages risk 
stratification for all persons at risk of CHD 
including those with hypertension. This is 
advantageous for timely intervention in 
p r e v e n t i n g  C H D  a n d  i t s '  s e q u e l a e .  
Cardiovascular risk assessment based solely on 
serum low density lipoprotein cholesterol (LDL-
C) has been found to be inadequate (14, 15) and 
even in those on statin therapy with normal or 
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as low risk (<0.1), intermediate risk (0.1–0.24), 
and high risk (>0.24).
The data was analysed using IBM© 
SPSS version 22. A descriptive analysis of socio-
demographic characteristics, biophysical, 
biochemical and clinical profile was done. 
Inferential statistics on determinants of 
atherogenic index risk was performed using t-test 
and F-tests. These formed the basis for regression 
analyses (simple and binary). The levels of 
significance were set at 95% confidence interval 
(95% CI) while p-value of < 0.05 was set to be 
statistically significant.
RESULTS
Table 1 shows the socio-demography 
and clinical profile of patients. The mean age of 
participants was 56±12 years. Patients within the 
age group 41-60 years constituted the majority 
(47.6%) of the study population while females 
predominate in all the age group except in those 
aged ≤ 40years with slightly lower proportion 
(49.0%). Majority (74.6%) were married and 
largely engaged in small business (49.2%).
Biochemically, only 23.0% of the 
patients whose blood samples were analysed for 
TC had desirable (normal) TC (≤ 5.2mmol/l) 
while majority 75.9% had high TC. However, 
69.4% had desirable triglyceride, 49.5% and 
78.5% had normal HDL-c and LDL respectively 
(Table 1).
Biophysical characteristics revealed that 
3.7% of the patients were underweight with BMI 
<18.5 while over a quarter (36.9%) were 
overweight. Higher proportions of female 
participants were found to be overweight and 
obese accounting for 67.4% and 87.7% 
respectively. Similarly, higher proportions of 
females (55.7%) had uncontrolled BP than the 
males (44.3%). 
Atherogenic risk: More than a quarter of 
participants (31.4%) had high atherogenic risk (> 
0.24). Gender stratification shows that high 
atherogenicity was higher among female patients 
than males (60.0% and 40.0% respectively). 
Factors associated with atherogenic risk are as 
shown in table 2. Participants whose ages were ≤ 
40years and ≥ 61years had higher proportions 
(40.8% and 33.6%) of high Atherogenic risk 
respectively, however, this association was not 
found to be statistically significant (p- value = 
0.164). Furthermore, 28.6% of participants with 
high TC had intermediate Atherogenic risk, while 
59.8% of those with high TG and 55.0% of 
abnormal HDL had high Atherogenic risk with 
varying statistical significance (p-values of 
Medical Outpatient Department) of the 
University of Ilorin Teaching Hospital (UITH), 
Ilorin, Nigeria. The hospital serves as a tertiary 
health facility and receives referral from public 
and private hospitals from within and outside the 
state. Adult patients (of over 18 years of age) with 
hypertension, or having both hypertension and 
diabetes were recruited into the study. Desired 
sample size of 382 patients was recruited using 
systematic random allocation over 6 months in 
2016.
Informed consent and Ethics
Informed consent was obtained from 
eligible patients after explaining research 
concept to the patients in the language they best 
understand. Ethical approval for this study was 
obtained from the UITH Ethical Review 
Committee. 
Data collection and analysis
Data was collected using Clinical Report 
Form (CRF) and a standardised questionnaire. 
The CRF was used to collect data on patients' 
medical information and records of parameters 
such as; BP, BMI, biochemical profile, disease 
history, drug history, complication and co-
morbidity history and hospital follow-up history. 
An interviewer-administered questionnaire was 
used to collect information on socio-
demography.
Measurement
Physical Measurement: Blood pressure 
measurement, height and weight were measured 
as described by Riha et al (25). Participants found 
to have systolic blood pressure ≥140mmHg 
and/or diastolic pressure ≥ 90mmHg were 
referred to as having poorly controlled 
hypertension. Participant categorization using 
BMI was as follows: BMI ≤ 18.5, “underweight,” 
BMI 18.5–24.9, “normal weight,” BMI 25–29.9, 
“overweight,” and BMI ≥ 30, “obese”. 
Laboratory Measurement:  Participants 
underwent phlebotomy where blood samples for 
lipid profile (TC, TG, HDL-C, and LDLC) were 
collected. Blood samples were transported on the 
same day of collection to a central laboratory for 
processing and testing. Lipid profile analysis was 
done using the enzymatic colorimetric assay by 
the Cobas Integra 400 Plus©. Cut-off values for 
the different lipid parameters representative of 
dyslipidemia were as follows: TC >5.2mmol/L, 
TG >2.3mmol/L, LDLC >3.4mmol/L and HDL-
C <1.04mmol/L for male, and <1.3mmol/L for 
female. Atherogenic risk profile, was categorized 
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association with high atherogenic risk in this 
study were abnormal TC, high TG and low serum 
level of HDL. A high serum level of TG and low 
serum HDL are integral of what constitute 
dyslipidaemia. This finding is in conformity with 
a population-based survey done in Iran and using 
the atherogenic index found a similar high 
estimate of atherogenic risk (27). Similarly, study 
involving 52 countries spread across all 
continents (INTERHEART study), found that 
persons with history of myocardial infarction had 
three times the odds of having atherogenic 
dyslipidemia compared to persons without 
history of myocardial infarction (28). 
Furthermore, an observational study done in 
Brazil found that persons with coronary disease 
had two times the odds of having an abnormal 
TG/HDL-C ratio (29). Although not found to be 
statistically significant in this study, high serum 
glucose level was also associated with high 
atherogenic risk. Diabetes affects the integrity of 
the vasculature and is also associated with other 
conditions that predispose to CHD, such as 
hypertension and dyslipidemia that may explain 
the increased risk (4).
Regression analyses revealed that the 
determinants of atherogenic risk were serum TG, 
HDL and serum LDL with significance at < 
0.001. Participants with high TC were 1.64 times 
of having high atherogenic risk, while those with 
high LDL, overweight, obese, uncontrolled BP 
and high serum glucose were 1.43, 1.48, 1.34, 
1.17 and 1.23 times of developing high 
atherogenic risk respectively. Previous 
epidemiological studies have shown that 
cholesterol, uncontrolled BP and serum glucose 
were predictors of CHD and LDL-C was 
associated with future risk (30); this is in tandem 
with our findings in this study. Similar to the 
Framingham and the INTERHEART studies (28, 
30) obesity and overweight were associated with 
high atherogenic risk in this study population.
CONCLUSION
A significant proportion of participants 
in this study population are at risk of developing 
atherosclerosis. Persons with uncontrolled 
hypertension, dyslipidaemia and uncontrolled 
glycaemia, appear to be more at risk and may be 
considered as target groups for intervention 
programs. Follow-up studies are needed to 
further assess the risk among younger age group. 
Assessment of atherogenic index for all patients 
at risk of developing metabolic syndrome should 
be given due consideration by healthcare 
providers since it has been established to provide 
0.048, < 0.001 and < 0.001 respectively). 
However, obesity, uncontrolled BP and high 
serum glucose among the study subjects were 
found not to be statistically significant. 
Tables 3 and 4 demonstrate regression 
analyses. Simple linear regression revealed that 
TG, HDL and LDL had linear relationship with 
high atherogenic risk as an independent entity 
with significance at < 0.001. For every unit 
increase of atherogenic index; there was a 
corresponding increase in the serum level of TG 
by 0.540 mmol/L, and 0.062mmol/L increase for 
LDL. Conversely, for every decrease in a unit of 
atherogenic index, there was a corresponding 
decrease in the serum level of (abnormal) HDL by 
-0.775mmol/l.   
Predictors of high atherogenic risk on 
binary regression were TC, LDL, abnormal BMI 
(overweight and obese), uncontrolled BP and 
high serum glucose. Participants with high TC 
were 1.64 times of having high atherogenic risk, 
while those with high LDL, overweight, obese, 
uncontrolled BP and high serum glucose were 
1.43, 1.48, 1.34, 1.17 and 1.23 times of 
developing high atherogenic risk respectively.   
DISCUSSION
This study revealed that over three-
quarter of the patients being followed-up at UITH 
Ilorin, had hypercholesterolaemia (TC) while 
half of them had dyslipidaemia (low serum HDL) 
which was more pronounced among female 
patients. This implied increased risk of 
developing CHD and worsened medical outcome 
(4). Similarly, large proportion of the study 
participants were obese and had uncontrolled BP 
despite being on treatment. These indicated 
inadequate treatment which could be multi-
factorial and corroborated findings from other 
studies that reported medical follow-up for 
hypertension in Nigeria. The study has 
established that both weight and uncontrolled BP 
are independent risks for CVD and CHD (4).
About a third (31.4%) of the participants 
had high atherogenic risk, of which females 
constituted majority (60%). This finding is higher 
compared to a similar study in Uganda where 
only a quarter had high atherogenic risk (4). 
Conversely, females were more at risk in our 
study than that of Ugandan study where males 
had higher risk. Almost half (49.5%) of the 
participants had uncontrolled BP with females 
being majority (55.7%) and the most likely 
explanation could be that females constituted the 
majority of the study population. 
Factors that showed significant 
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Table 1: Sociodemographic, clinical, physical, and biochemical characteristics of Patients by gender. 
 
Variables All participants (%) Gender ÷2 Ñ 
Demographic  Male (%) Female (%)   
*Age Group      
= 40 66 (17.3) 34 (51.0) 32 (49.0)   
41 – 60 182 (47.6) 55 (30.2) 127 (69.8)   
= 61 134 (35.1) 52 (38.8) 82 (61.2) 7.875 0.019 
Level of Education      
Primary 69 (18.1) 29 (40.6) 41 (59.4)   
Secondary 73 (19.1) 36 (49.3) 37 (50.7)   
Quranic 9 (2.4) 2 (22.2) 7 (77.8)   
Tertiary 104 (27.2) 57 (54.8) 47 (45.2)   
Vocational training 9 (2.4) 5 (55.6) 4 (44.4)   
No formal education 118 (30.9) 7 (5.9) 111 (94.1) 71.263 < 0.001 
Marital Status      
Married 285 (74.6) 121 (42.5) 164 (57.5)   
Single 5 (1.3) 4 (80.0) 1 (20.0)   
Divorced 8 (2.1) 4 (50.0) 4 (50.0)   
Widowed 84 (22.0) 6 (7.1) 78 (92.9) 40.660 < 0.001 
Occupation      
Small business 188 (49.2) 44 (23.4) 144 (76.6)   
Large business 22 (5.8) 8 (36.4) 14 (63.6)   
Civil servant 116 (30.4) 51 (44.0) 65 (56.0)   
Unemployed 55 (14.4) 32 (58.2) 23 (41.8) 28.031 < 0.001 
Biochemical 
characteristics 
     
Total cholesterol      
Desirable (=5.2mmol/l) 88 (23.0) 32 (36.4) 56 (63.6)   
High (>5.2mmol/l) 290 (75.9) 102 (35.2) 188 (64.8) 0.042 0.838 
Triglyceride      
Desirable (=2.3mmol/L) 265 (69.4) 93 (35.1) 172 (64.9)   
High (>2.3mmol/L) 117 (30.6) 42 (35.9) 75 (64.1) 0.023 0.880 
HDL-C      
Abnormal (<1.04-m, 1.3-f), 
low 
191(50.0) 76 (39.8) 115 (60.2)   
Normal (=1.04-m, 1.3-f) 189 (49.5) 57 (30.2) 132 (69.8) 3.874 0.049 
LDL-C      
Normal (=3.4mmol/L) 300 (78.5) 110 (36.7) 190 (63.3)   
High (>3.4mmol/L) 82 (21.5) 25 (30.5) 57 (69.5) 1.076 0.300 
Serum glucose      
Normal (< 11mmol/L) 340 (89.0) 119 (35.0) 221 (65.0)   
High(= 11mmol/L) 36 (9.4) 14 (38.9) 22 (61.1) 0.215 0.643 
Biophysical characteristic      
BMI      
Underweight (<18.5) 14 (3.7) 7 (50.0) 7 (50.0)   
Normal (18.5–24.9) 118 (30.9) 67 (56.8) 51 (43.2)   
Overweight (=25) 141(36.9) 46 (32.6) 95 (67.4)   
Obese  106 (27.7) 13 (12.3) 93 (87.7) 50.361 < 0.001 
Clinicalcharacteristics      
Blood Pressure      
Controlled  (<140/90 
mmHg) 
233 (61.0) 69 (29.6) 164 (70.4)   
Uncontrolled (=140/90 
mmHg) 
189 (49.5) 66 (44.3) 83 (55.7) 8.573 0.003 
Atherogenic risk      
Low (<0.1) 262 (68.6) 87 (33.2) 175 (66.8)   
High (>0.24) 120 (31.4) 48 (40.0) 72 (60.0) 1.662 0.197 
 
* Mean ±SD =56±12 yrs  
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Table 2: factors associated with Atherogenic risk among patients 
 
Variables Antherogenic  ÷2 Ñ 
Demographic Low (%) High (%)    
Age Group     
= 40 29 (59.2) 20 (40.8)   
41 – 60 144 (72.4) 55 (27.6)   
= 61 89 (66.4) 45 (33.6) 3.620 0.164 
Gender     
Male 87 (64.4) 48 (35.6)   
Female 175 (70.9) 72 (29.2) 1.662 0.197 
Biochemical characteristics     
Total cholesterol     
Normal 53 (60.2) 35 (39.8)   
Abnormal  207 (71.4) 83 (28.6) 3.910 0.048 
Triglyceride     
Normal 215 (81.1) 50 (18.9)   
Abnormal 47 (40.2) 70 (59.8) 63.206 < 0.001 
HDL-C     
Abnormal  86 (45.0) 105 (55.0)   
Normal 174 (92.1) 15 (7.9) 97.277 < 0.001 
LDL-C     
Normal 201 (67.0) 99 (33.0)   
Abnormal 61 (74.4) 21 (25.6) 1.632 0.201 
Serum glucose     
Normal 233 (68.5) 107 (31.5)   
High 23 (63.9) 13 (36.1) 0.323 0.570 
BMI     
Underweight 10 (71.4) 4 (28.6)   
Normal 77 (65.3) 41 (34.7)   
Overweight 95 (67.4) 46 (32.6)   
Obese 78 (73.6) 28 (26.4) 1.986 0.575 
Blood Pressure     
Controlled  (<140/90 
mmHg) 
163 (70.0) 70 (30.0)   
Uncontrolled (=140/90 
mmHg) 
99 (66.4) 50 (33.6) 0.521 0.470 
 
 













Total Cholesterol (TC)  -0.072 -1.395 0.164 -0.026 0.004 
Trigliceride (TG) 0.540 12.514 <0.001 0.150 0.206 
HDL (abnormal)  -0.775 -23.919 <0.001 -0.309 -0.262 
LDL 0.062 3.612 <0.001 0.006 0.019 
Serum Glucose -0.003 -0.571 0.568 -0.008 0.004 
BMI -0.004 -0.280 0.780 0.000 0.000 
Average Systolic Dominant 0.036 0.708 0.480 -0.001 0.001 
Average Diastolic Dominant 0.049 0.962 0.337 -0.001 0.002 
Age -0.024 -1.647 0.100 -0.001 0.000 
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Table 4: Binary regression analysis of high atherogenic risk of patients 
 
Variables Â Ñ Odd Ratio 
95% C.I 
Lower Upper 
Age      
> 60 (RC)  .168    
= 40 -0.599 0.073 0.549 0.285 1.059 
41 – 60 -0.310 0.366 0.733 0.374 1.437 
Cholesterol       
Total cholesterol 
(high) 
0.499 0.049 1.647 1.002 2.707 
Triglyceride (high) -1.857 < 0.001 0.156 0.097 0.253 
HDL (abnormal) -2.651 < 0.001 0.071 0.039 0.129 
LDL (high) 0.358 0.203 1.431 0.824 2.483 
BMI      
Underweight (RC)      
Normal 0.108 0.864 1.114 0.323 3.840 
Overweight 0.394 0.179 1.483 0.835 2.635 
Obese  0.299 0.292 1.349 0.773 2.355 
Blood pressure      
Controlled (RC)      
Uncontrolled 0.162 0.471 1.176 0.757 1.827 
Serum glucose      
Serum glucose (high) 0.208 0.571 1.231 0.601 2.522 
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